Offering opportunistic HPV vaccine during routine sexual health clinic visits clinical trials

HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks

This study in Scotland looks at how best to offer the HPV vaccine to women aged 25-45 who may be at higher risk of cervical cancer. It aims to improve vaccination rates and understand people's experiences.